~~<i id='7C87473D5A'><strike id='7C87473D5A'><tt id='7C87473D5A'><pre id='7C87473D5A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：hotspot 2025-10-03 00:39:02 - browse：17597

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Lecanemab for Alzheimer's is coming. Is the health system ready?

leisure time

hotspot

leisure time

knowledge

Wikipedia

leisure time

1:30Twosixty-five-footraceyachtshadacloseencounterwithorcawhalesastheyapproachedtheStraitofGibraltar

WSS

Moderna hits safety problems in bold bid to reinvent medicine

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

N.Y. state detects polio case, first in the U.S. since 2013

A new study sees potential in DNA sequencing of infants

Lecanemab for Alzheimer's is coming. Is the health system ready?

Why workplace violence is so common in health care

explore

explore

leisure time

In Memoriam: Notable people who died in 2023

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

In age of alternative facts, a scholarly course on calling out crap

Mississippi candidates for statewide offices square off in party primaries

Malaria cases in Florida and Texas: Here’s what you need to know

Palantir health business leans on meeting customers’ needs

Anesthesiologist group: stop taking Ozempic before surgery

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Walensky prepares to leave CDC — and Congress — behind

Study: Pain burden is higher in Black NFL players than white ones

hotspot

HCA discloses massive data breach affecting 11 million patients

Why 40% Americans with Parkinson’s don’t see a neurologist

A new study sees potential in DNA sequencing of infants

Mississippi candidates for statewide offices square off in party primaries

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

At least 12 people were injured in a blast at a port in northwest Turkey

leisure time

knowledge

Wikipedia

leisure time